Orgovyx 120 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FV283
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,460
Award facts
- Contract value 100% obligated
- $1,460.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 6, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $1,460.13 to AmerisourceBergen Drug Corp for the supply of ORGOVYX 120 MG tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 28, 2026, with performance based in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which carries a $999,999,999.00 ceiling value through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA IDC enables it to supply a broad spectrum of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized healthcare commodities—across multiple therapeutic domains. This delivery order for ORGOVYX, a specialized pharmaceutical treatment, reflects the company's capability to fulfill targeted federal medical supply requirements through the DLA's competitive pharmaceutical procurement framework.
Quick answers
Who was awarded contract SPE2DR26FV283?
SPE2DR26FV283 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FV283 worth?
The government has obligated $1,460 on SPE2DR26FV283.
Is contract SPE2DR26FV283 an order under another contract?
Yes. SPE2DR26FV283 is a delivery order under SPE2DR25D1053, an indefinite delivery contract.
Was contract SPE2DR26FV283 competed?
The extent of competition for SPE2DR26FV283 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award